Company

Shanghai Henlius Biotech, Inc.

Shanghai Henlius Biotech, Inc. researches and sells antibody drugs for oncology, autoimmune and ophthalmic diseases.

About

Founded in 2010 and based in Shanghai, China, Shanghai Henlius Biotech, Inc. is a biopharmaceutical company focused on antibody drugs and related products. Its pipeline includes more than 20 monoclonal antibody and tumor immunology combination therapy candidates, and it has conducted over 30 clinical studies for 16 products globally. Jun Zhu is executive director and CEO. The company was listed on the Hong Kong Exchanges and Clearing Limited in September 2019.

4Funding rounds

6Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in